medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2003, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2003; 50 (2)

Evaluation of the citrate dextrose phosphate anticoagulant for the hematologic parameters determination in oncologic patients

Torrella GA, Toledo GR, Hondares CMF, Calañas SL

Language: Spanish
References: 12
Page: 77-81
PDF size: 55.08 Kb.


ABSTRACT

In this work it was our purpose to evaluate the citrate dextrose phosphate (CDP) as anticoagulant for the hematic biometry, the prothrombin time and the partial thromboplastin time in oncology patients with the objective to use only one blood sample of 2 mL. In the comparison of the evaluated anticoagulant with the reference anticoagulants were obtained correlation coefficients upper to 0.90. These results allowing the utilization of CDP in these laboratory tests and the use of only one sample with less volume. This represent one benefit for the oncology patients over all for the children if take in consideration that in these patients is difficult to draw the blood and to obtain the volume required.


REFERENCES

  1. Kaplan EB, Sheiner LB, Boeckman AJ et al. The usefulness of preoperative laboratory screening. JAMA 1985; 253: 3576-3578.

  2. Kitchen CS. Prolonged activated partial thromboplastin time of unknown etiology: A prospective study of 100 consecutive cases referred for consultation. Am J Hemat 1988; 27: 38-45.

  3. Miale JB, Winningham AR. A true micromethod for prothrombin time using capillary blood and disposable multipurpose micropipet. Am J Clin Pathol 1960; 33: 124-128.

  4. Quick AJ. Hemorrhagic diseases and thrombosis. 2nd ed. Philadelphia: Lea and Febiger, 1966.

  5. Sachman AL, Grinner PF. Diagnostic uses of the activated partial thromboplastin time and prothrombin time. Ann Intem Med 1986; 256: 750-753.

  6. Vives JL, Aguilar JL. La sangre, características generales y métodos de extracción sanguínea. Empleo de anticoagulantes. En: Manual de técnicas de laboratorio en hematología. Barcelona, España: Salvat Editores, 1987: 19.

  7. Ruiz BE, Abrajam LD. Valoración del citrato dextrosa fosfato como anticoagulante para determinar la biometría hemática. Rev Mex Patol Clin 1996; 42 (3): 119-121.

  8. Ruiz BE. Determinación del tiempo de protrombina y tiempo de tromboplastina parcial utilizando citrato dextrosa fosfato como anticoagulante. Rev Mex Patol Clin 1996; 44 (4): 152-157.

  9. Vives JL, Aguilar JL. Métodos para la determinación de la hemoglobina en sangre. Método de la cianometahemoglobina. En: Manual de técnicas de laboratorio en hematología, Capítulo 5 Hemoglobina y sus derivados. Características generales y métodos para su determinación cuantitativa. Barcelona, España: Salvat Editores, 1987: 91.

  10. Branum E, Cummins L, Bartilson M et al. Effect of two anticoagulants on leukocyte yield and function and on lysosomal enzyme activity. Clin Chem 1988; 34 (1): 110-113.

  11. Loutit JF, Mollison PL, Young IM. Citric acid sodium citrate-glucose mixtures for blood storage. QJ Exp Physiol 1943; 32: 183-202.

  12. Moore SB, Beckala H, DeGoey S, Leavelle D. A report on the use of ACD (solution B) as whole blood transport medium for recovery of lymphocytes for HLA typing. In: Zachary AA, Braun WE (eds). New York: Laboratory Manual. Amer Asoc for Clin Histocompatibility Testing, 1981: I-27-1-I-27-6.




2020     |     www.medigraphic.com